Conference Evaluation and Certificate of Attendance Request Process
A Certificate of Attendance will be available at the conclusion of the conference. To complete the post-conference materials please go to:
About this Conference
"The History and Future: Kidney, Liver and Hematopoietic Stem Cell Transplantation" is designed to offer an overview of the evolution of three common categories of transplantation. Faculty who actively practice transplantation and transplant management in their specific areas of expertise will provide the audience with a historical base, current standard of care, and a glimpse into the future of the whole transplant process. The audience will learn how all aspects of the transplant process may be impacted by Health Care Reform, availability of organs, our aging population, and individual psychosocial and socioeconomic situations.
Presentations will cover both the basics and the details, from teaching the difference between an autologous or allogeneic stem cell transplant to helping health care professionals determine whether a person with hepatocellular cancer really should be considered an appropriate transplant recipient. These and other questions will be answered by the expert clinicians who work with these issues and patients everyday.
This conference is designed for health care professionals who care for and/or manage patients' health care benefits, and who have an interest in Kidney, Liver, and Hematopoietic Stem Cell (HSC) transplant medicine.
Who Should Attend
- Case Managers
- Managed Care Professionals
- Oncology Nurses
- Transplant Nurses
- Transplant Coordinators
- Medical Directors
- Medical Management Staff
- Utilization Review Staff
- Reinsurance Managers
- Social Workers
- Other Health Care Professionals committed to managing and improving patient care
Conference Educational Objectives
Upon successful completion of this conference, participants should be able to:
- Recognize specific clinical situations wherein HSC transplantation is appropriate, and differentiate between allogeneic HSC and autologous HSC;
- Identify the infection risks associated with HSC transplantation, and name the most common medications used to treat or prevent these infections;
- Review the current state and prevalence of kidney disease in the United States today, and relate how the stage of disease determines the most appropriate treatment based on current treatment guidelines;
- Describe strategies for the prevention and management of transplant-related complications post liver transplant, including the role of immunosuppression; and
- Integrate the psychosocial, medical, and financial challenges specific to the transplant referral and evaluation process in order to identify any possible barriers to a successful transplant outcome.